Article
New Orleans - Topical imiquimod (Aldara) treatment may play a role in preventing UVB-induced cutaneous immunosuppression, Anthony A. Gaspari, M.D., said at the annual meeting of the American Academy of Dermatology.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.